Erin L. Volk, Ph.D.

2003 State University of New York, Albany, Albany, NY, United States 
Cell Biology, Molecular Biology, Oncology
"Erin Volk"


Sign in to add mentor
Erasmus Schneider grad student 2003 SUNY Albany
 (Breast cancer resistance protein mediates methotrexate efflux and resistance.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Volk EL, Pankuch JJ, Chave KJ, et al. (2003) A rapid assay for the quantitation of gamma-glutamyl hydrolase using a fluorogenic peptide as substrate. Biotechniques. 35: 926-8, 930, 932
Volk EL, Schneider E. (2003) Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Research. 63: 5538-43
Volk EL, Farley KM, Wu Y, et al. (2002) Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Research. 62: 5035-40
Diah SK, Smitherman PK, Aldridge J, et al. (2001) Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Research. 61: 5461-7
Yang CH, Schneider E, Kuo ML, et al. (2000) BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochemical Pharmacology. 60: 831-7
Volk EL, Rohde K, Rhee M, et al. (2000) Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Research. 60: 3514-21
Rocchi E, Khodjakov A, Volk EL, et al. (2000) The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochemical and Biophysical Research Communications. 271: 42-6
See more...